SamanthaA.SeawardMD

Radiation Oncology • Santa Clara, CA

Physician

Join to view full profile

Dr. Seaward is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Seaward's full profile

Already have an account?

Office
900 Kiely Blvd
Santa Clara, CA 95051
Phone+1 408-236-6400

Education & Training

University of California (San Francisco)Residency, Radiation Oncology, 1996 - 2000
Presbyterian Medical Center of the University of Pennsylvania Health SystemInternship, Transitional Year, 1995 - 1996
David Geffen School of Medicine at UCLAClass of 1995

Certifications & Licensure

CA State Medical License 1997 - 2026
MD State Medical License 2009 - 2025
American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011

Clinical Trials

Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer Start of enrollment: 2011 Feb 14
Completed
Phase 3
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer Start of enrollment: 2011 Jul 01
Active, not recruiting
Phase 3
Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma Start of enrollment: 2011 Sep 01
Completed
Phase 2
Radiation Therapy in Treating Patients With Prostate Cancer Start of enrollment: 2011 Sep 01
Completed
Phase 2
Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer Start of enrollment: 2012 May 01
Active, not recruiting
Phase 3
Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer Start of enrollment: 2012 Nov 01
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

2 citations
Long-Term Analysis of NRG Oncology RTOG 0415: A Randomized Phase III Noninferiority Study Comparing Two Fractionation Schedules in Patients With Low-Risk Prostate Cancer.
W Robert Lee, James J Dignam, Mahul B Amin, Deborah W Bruner, Daniel Low
Journal of Clinical Oncology. 2024-07-10
2 citations
Analysis of Radiation Therapy Quality Assurance in NRG Oncology RTOG 0848.
Leila T Tchelebi, Kathryn A Winter, Ross A Abrams, Howard P Safran, William F Regine
International Journal of Radiation Oncology, Biology, Physics. 2024-01-01
14 citations
Five-Year Patient-Reported Outcomes in NRG Oncology RTOG 0938, Evaluating Two Ultrahypofractionated Regimens for Prostate Cancer.
Himanshu R Lukka, Snehal Deshmukh, Deborah W Bruner, Jean-Paul Bahary, Colleen A F Lawton
International Journal of Radiation Oncology, Biology, Physics. 2023-07-15